4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-001422
Director sold 4,720 shares at an average $38.10 ($179,813)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vakiener Victoria Director | 2024-01-11 | Sale 10b5-1 | −3,620 | $37.87 | $137,089 | 33,101 | D |
| Vakiener Victoria Director | 2024-01-11 | Sale 10b5-1 | −1,100 | $38.84 | $42,724 | 32,001 | D |
| Open-market sales · 4,720 sh · avg $38.10 · $179,813 | |||||||
Loading xslF345X05/wk-form4_1705446365.xml…